Jane Street Group, LLC Atossa Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 136,935 shares of ATOS stock, worth $128,718. This represents 0.0% of its overall portfolio holdings.

Number of Shares

136,935

Previous 260,081 47.35%

Holding current value

$128,718

Previous $309,000 32.69%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.09 - $1.52 $134,229 - $187,181	-123,146 Reduced 47.35%	136,935 $208,000
Q2 2024 Aug 14, 2024	BUY	$1.03 - $2.1 $227,658 - $464,158	221,028 Added 565.97%	260,081 $309,000
Q1 2024 May 15, 2024	BUY	$0.8 - $1.89 $31,242 - $73,810	39,053 New	39,053 $70,000
Q3 2023 Nov 14, 2023	SELL	$0.74 - $1.35 $45,561 - $83,118	-61,569 Reduced 78.06%	17,302 $12,000
Q2 2023 Aug 14, 2023	BUY	$0.6 - $1.28 $33,786 - $72,076	56,310 Added 249.59%	78,871 $99,000
Q1 2023 May 15, 2023	SELL	$0.59 - $0.91 $12,572 - $19,392	-21,310 Reduced 48.57%	22,561 $16,000
Q4 2022 Feb 14, 2023	BUY	$0.5 - $1.01 $16,385 - $33,098	32,771 Added 295.23%	43,871 $23,000
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.14 $55,913 - $77,733	-68,187 Reduced 86.0%	11,100 $9,000
Q2 2022 Aug 16, 2022	SELL	$0.85 - $1.28 $33,295 - $50,138	-39,171 Reduced 33.07%	79,287 $86,000
Q1 2022 May 17, 2022	SELL	$1.11 - $1.74 $22,796 - $35,734	-20,537 Reduced 14.78%	118,458 $148,000
Q4 2021 Feb 15, 2022	SELL	$1.6 - $3.27 $129,193 - $264,039	-80,746 Reduced 36.75%	138,995 $222,000
Q3 2021 Nov 16, 2021	SELL	$2.89 - $6.4 $3.19 Million - $7.07 Million	-1,103,908 Reduced 83.4%	219,741 $716,000
Q2 2021 Aug 16, 2021	BUY	$1.52 - $8.62 $1.87 Million - $10.6 Million	1,228,839 Added 1296.11%	1,323,649 $8.37 Million
Q1 2021 May 18, 2021	BUY	$0.92 - $4.33 $87,225 - $410,527	94,810 New	94,810 $200,000
Q1 2019 May 16, 2019	SELL	$1.11 - $7.07 $24,796 - $157,936	-22,339 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$0.92 - $1.67 $1,152 - $2,092	-1,253 Reduced 5.31%	22,339 $23,000
Q3 2018 Nov 14, 2018	BUY	$1.47 - $2.78 $34,680 - $65,585	23,592 New	23,592 $41,000

Others Institutions Holding ATOS

# of Institutions

Shares Held

26.5M

Call Options Held

466K

Put Options Held

91.8K

View Full List

About ATOSSA THERAPEUTICS, INC.

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $119M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

More about ATOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Atossa Therapeutics, Inc. Transaction History